Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Int. braz. j. urol ; 40(2): 154-160, Mar-Apr/2014. tab
Article Dans Anglais | LILACS | ID: lil-711693

Résumé

Introduction and objectiveActive surveillance (AS) has become an accepted alternative for patients with low risk prostate cancer. The purpose of AS is to defer definitive therapy in these patients to avoid treatment-related complications. Our aim was to determine the pathological features of the surgical specimen from potential AS candidates that underwent radical prostatectomy (RP).Materials and MethodsWe retrospectively reviewed a group of patients submitted to RP who met criteria for AS: Gleason score (GS) ≤ 3+3 = 6, PSA ≤ 10ng/mL, T1c - T2a, < 1/3 of positive cores, < 50% of involvement in any core and PSA density < 0.15. We determined the concordance between GS in biopsy and RP specimen (RPS). Other pathological features of the RPS were also analyzed, including surgical margins, extracapsular extension, seminal vesicles and lymph node involvement.ResultsWe identified 167 patients subjected to RP that met the criteria for AS. Fifty two patients (31.1%) had a GS > 6 in the RPS (GS 7 n = 49; GS 8 n = 3). Extracapsular extension, seminal vesicle and lymph node involvement was found in 6.1%, 3.1% and 1.2% of the specimens, respectively.ConclusionIn this study a significant proportion of potential candidates for AS showed features of aggressive and/or high-risk tumors in the RPS. Therefore, before considering a patient for an AS protocol, a proper and strict selection must be performed, and informed consent is crucial for these patients.


Sujets)
Adulte , Sujet âgé , Humains , Mâle , Adulte d'âge moyen , Prostatectomie/méthodes , Tumeurs de la prostate/anatomopathologie , Tumeurs de la prostate/chirurgie , Observation (surveillance clinique)/méthodes , Biopsie , Loi du khi-deux , Prise en charge de la maladie , Noeuds lymphatiques/anatomopathologie , Grading des tumeurs , Stadification tumorale , Antigène spécifique de la prostate/sang , Prostate/anatomopathologie , Prostate/chirurgie , Études rétrospectives , Appréciation des risques , Facteurs de risque , Facteurs temps , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche